The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated Covid shots, among others.

Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn't make sense, former officials said.

Regulators sent about 100 warning letters this week to drug advertisers, including to Hims & Hers, a major online provider of weight-loss drugs.

U.S. Food and Drug Administration Commissioner Martin Makary said on Friday that Hims & Hers' Super Bowl advertisement breached federal law as it highlighted the benefits of weight-loss drugs without mentioning side effects.

Top Food and Drug Administration regulator Vinay Prasad has regained his role as the agency’s chief medical and scientific officer after he abruptly departed and then came back to the agency, according to an update on the agency’s website Thursday.

President Donald Trump wants drugmakers to lower their prices in the US — so he’ll push them to raise prices in other countries to offset the hit to their bottom line, Commerce Secretary Howard Lutnick said Friday.

In a hastily scheduled meeting, Kenvue interim Chief Executive Kirk Perry sought to dissuade the health secretary, arguing there is no clear link.

Millions in military and development funds for Colombia hang in the balance as Washington questions the country’s fight against cocaine.

HHS and the FDA will close a 1997 loophole that allowed drug companies to limit the number of side effects disclosed in TV commercials.